消炎剤の世界市場予測

◆英語タイトル:The Global Anti-Inflammatory Therapeutics Market Forecast 2017-2027
◆商品コード:VGAIN7081170
◆発行会社(調査会社):visiongain
◆発行日:2017年6月
◆ページ数:162
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:製薬
◆販売価格オプション(消費税別)
Sigle User(1名閲覧)GBP2,499 ⇒換算¥372,351見積依頼/購入/質問フォーム
Five UserGBP2,999 ⇒換算¥446,851見積依頼/購入/質問フォーム
Site License(全社内共有可)GBP4,999 ⇒換算¥744,851見積依頼/購入/質問フォーム
※visiongain社発行の調査レポートは、Single UserとDept Licence(Five User)の場合、DRM(デジタル著作権管理)付PDFファイルです。認証されたPC上のみでの閲覧と、PDF閲覧期限は購入日より1年となります。Dept Licence(Five User)は印刷できますが、Single Userは印刷できません。Site Licence/Global Site Licenseの場合は、閲覧・印刷制限はありません。

販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はvisiongain社の日本における正規販売代理店です。visiongain社の概要及び新刊レポートはこちらでご確認いただけます。
visiongain社が発行した当調査レポートでは、消炎剤の世界市場について調査・分析し、消炎剤の世界市場規模、市場動向、市場予測、関連企業情報などを含め、以下の構成でお届けいたします。
・レポートの概要
・イントロダクション
・消炎剤の世界市場
 (市場規模予測、市場動向、市場の成長要因・阻害要因など)
・消炎剤の世界市場:セグメント別市場分析
・消炎剤の世界市場:地域別市場分析、市場規模予測
・市場環境分析
・専門家の見解
・主要企業分析
・結論
【レポートの概要】

Anti-Inflammatory Therapeutics – our new study reveals trends, R&D progress, and predicted revenues
Where is the Anti-Inflammatory Therapeutics market heading? If you are involved in this sector you must read this brand new report. Visiongain’s report shows you the potential revenues streams to 2027, assessing data, trends, opportunities and business prospects there.

Discover How to Stay Ahead
Our 162-page report provides 108 tables, charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Anti-Inflammatory Therapeutics market. See how to exploit the opportunities.

Forecasts to 2027 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2027, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.

Discover sales predictions for the world market and submarkets
Along with revenue prediction for the overall world market, there are forecasts for 5 Indications and 4 Drug Classes

Anti-Inflammatory Therapeutics Market Forecasts to 2027, By Indication
• Arthritis
• Respiratory Conditions
• Multiple Sclerosis
• Inflammatory Bowel Diseases
• Other

Anti-Inflammatory Therapeutics Market Forecasts to 2027, By Drug Class
• Corticosteroids
• Anti-Inflammatory Biologics
• NSAIDs
• Other Anti-Inflammatory Therapeutics

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 11 leading national markets:
• The US
• Canada
• Germany
• France
• The UK
• Italy
• Spain
• Japan
• China
• India
• Russia
• Brazil

The report also includes profiles and forecasts for some of the leading companies in the Anti-Inflammatory Therapeutics market, with a focus on the Anti-Inflammatory Therapeutics segment of these companies’ operations.

There will be growth in both established and in developing countries. Our analyses show that the developing markets, China in particular, will continue to achieve high revenue growth to 2027. Developments worldwide in medical device regulation, especially in the US and Japan will influence the market.

Leading companies and the potential for market growth
Overall world revenue for Anti-Inflammatory Therapeutics will surpass $75bn in 2017, our work calculates. We predict strong revenue growth through to 2027. The increasing prevalence of autoimmune disease, and increasing ageing population will increase sales to 2027.

Our work identifies which organisations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Anti-Inflammatory Therapeutics Market report helps you
In summary, our 162-page report provides you with the following knowledge:
• Revenue forecasts to 2027 for the world Anti-Inflammatory Therapeutics market and 2 different segmentations, with forecasts for 5 Indications and 4 Drug Classes – discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2027 for 11 of the leading national markets – US, Germany, UK, France, Italy, Spain, Japan, China, Brazil, Russia, India
• Discussion of what stimulates and restrains companies and the market
• Prospects for established firms and those seeking to enter the market – including company profiles and forecasts for 8 companies’ anti-inflammatory segment revenues to 2027

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else
With our survey you are less likely to fall behind in knowledge or miss opportunity. See how you could benefit your research, analyses, and decisions. Also see how you can save time and receive recognition for commercial insight.

Visiongain’s study is for everybody needing commercial analyses for the Anti-Inflammatory Therapeutics market and leading companies. You will find data, trends and predictions.

Get our report today The Global Anti-Inflammatory Therapeutics Market Forecast 2017-2027: Revenue Prospects by Indication (Arthritis, Respiratory, MS, Psoriasis, IBD, Other), Drug Class (Corticosteroids, Anti-Inflammatory Biologics, NSAIDs, Other) and Geography. Avoid missing out – get our report now.

【レポートの目次】

1. Report Overview
1.1. The Global Anti-Inflammatory Therapeutics Market Overview
1.2. Global Anti-Inflammatory Therapeutics Market Segmentation
1.3. Overview of Findings
1.4. Structure of the Report
1.5. Why you should Read this Report?
1.6. How this Report Delivers
1.7. Key Questions Answered by this Report
1.8. Who is this Report for?
1.9. Methodology
1.10. Frequently Asked questions
1.11. Associated Visiongain Reports
1.12. About Visiongain

2. Introduction to Inflammation and Anti-Inflammatory Therapeutics
2.1 An Introduction to Inflammation
2.1.1 Causes of Inflammation
2.2 Types of Inflammation
2.2.1 Acute Inflammation
2.2.2 Chronic Inflammation
2.3 An Introduction to Anti-Inflammatory Therapeutics
2.4 Classification of Anti-Inflammatory Therapeutics
2.4.1 Anti-Inflammatory Therapeutics Segmentation by Indication
2.4.1.1 Arthritis
2.4.1.2 Respiratory Diseases
2.4.1.3 Multiple Sclerosis
2.4.1.4 Psoriasis
2.4.1.5 Inflammatory Bowel Disease
2.4.2 Anti-Inflammatory Therapeutics Segmentation, by Drug Class
2.4.2.1 Anti-Inflammatory Biologics
2.4.2.2 Non-Steroidal Anti-Inflammatory Drugs (NSAID’S)
2.4.2.3 Corticosteroids

3. Anti-Inflammatory Therapeutics World Market 2016-2027
3.1 Anti-Inflammatory Therapeutics: Global Market Overview, 2016
3.2 The World Anti-Inflammatory Therapeutics Market
3.3 World Anti-Inflammatory Therapeutics: Forecast to 2016-2027
3.4 Anti-Inflammatory Therapeutics Market Drivers and Restraints

4. Anti-Inflammatory Therapeutics by Indication: World Market 2017-2027
4.1 Anti-Inflammatory Therapeutics by Indication: Market Overview, 2016
4.2 Anti-Inflammatory Therapeutics: Market Forecast 2017-2027
4.3 Market Share of Anti-Inflammatory Therapeutics, by Indication
4.4 Arthritis, 2016-2027
4.5 Leading Drugs in Arthritis, 2016-2027
4.5.1 Simponi/Simponi Aria (Johnson & Johnson)
4.5.2 MabThera/Rituxan (Roche)
4.6 Psoriasis, 2016-2027
4.7 Leading Drugs: Psoriasis, 2016-2027
4.7.1 Humira (AbbVie)
4.7.2 Cosentyx (Novartis)
4.8 Respiratory Diseases, 2016-2027
4.9 Leading Drugs in Respiratory Diseases, 2016-2027
4.9.1 Xolair (Genentech)
4.9.2 Advair (GSK)
4.9.3 Flovent (GSK)
4.9.4 Symbicort(AstraZeneca)
4.10 Multiple Sclerosis, 2016-2027
4.11 Leading Drugs in Multiple Sclerosis, 2016-2027
4.11.1 Plegridy (Biogen)
4.11.2 Rebif (Merck)
4.12 Inflammatory Bowel Diseases, 2016-2027
4.13 Leading Drugs in Inflammatory Bowel Diseases, 2016-2027
4.13.1 Entyvio (Takeda)
4.14 Anti-Inflammatory Therapeutics Pipeline Analysis, 2016-2027

5. Anti-Inflammatory Therapeutics Market by Drug Class 2016-2026
5.1 Global Anti-Inflammatory Therapeutics Market Overview, 2016
5.2 Anti-Inflammatory Therapeutics by Drugs Class: Market Forecast 2016-2027
5.3 Market share of Anti-Inflammatory Therapeutics, by Drug Class
5.4 Corticosteroids, 2016-2027
5.5 Anti-Inflammatory Biologics, 2016-2027
5.6 Non-Steroidal Anti-Inflammatory Drugs, 2016-2027
5.7 Other Drugs, 2016-2027

6. Leading National Markets, 2016-2027
6.1 Geographical Breakdown of Global Anti-Inflammatory Therapeutics Market
6.2 Global Anti-Inflammatory Therapeutics Market: Regional Forecast 2016-2027
6.2.1 How Will Regional Market Shares Change to 2027?
6.3 The US Anti-Inflammatory Therapeutics Market 2016-2027
6.3.1 US Anti-Inflammatory Therapeutics Market Forecast 2016-2027
6.3.2 US Anti-Inflammatory Therapeutics Market: Trends and Developments
6.4 EU5 Anti-Inflammatory Therapeutics Market 2016-2027
6.4.1 EU5 Anti-Inflammatory Therapeutics Market Forecast 2016-2027
6.4.1.1 UK Anti-Inflammatory Therapeutics Market Forecast 2016-2027
6.4.1.2 Germany Anti-Inflammatory Therapeutics Market Forecast 2016-2027
6.4.1.3 France Anti-Inflammatory Therapeutics Market Forecast 2016-2027
6.4.1.4 Italy Anti-Inflammatory Therapeutics Market Forecast 2016-2027
6.4.1.5 Spain Anti-Inflammatory Therapeutics Market Forecast 2016-2027
6.5 The Japanese Anti-Inflammatory Therapeutics Market, 2016-2027
6.6 The Brazilian Anti-Inflammatory Therapeutics Market, 2016-2027
6.7 The Russian Anti-Inflammatory Therapeutics Market, 2016-2027
6.8 The Indian anti-inflammatory Therapeutics Market, 2016-2027
6.9 The Chinese Anti-Inflammatory Therapeutics Market, 2016-2027
6.10 The Rest of the World Anti-Inflammatory Therapeutics Market, 2016-2027

7. Leading Companies in the Anti-Inflammatory Therapeutics Market
7.1 Johnson & Johnson (J&J)
7.1.1 J&J: Anti-Inflammatory Therapeutics Product Portfolio
7.1.2 Johnson & Johnson Financial Overview
7.2 GlaxoSmithKline
7.2.1 GlaxoSmithKline: Anti-Inflammatory Therapeutics Product Portfolio
7.2.2 GlaxoSmithKline: Financial Overview
7.3 Novartis
7.3.1 Novartis: Anti-Inflammatory Therapeutics Product Portfolio
7.3.2 Novartis: Financial Overview
7.4 Pfizer
7.4.1 Pfizer: Anti-Inflammatory Therapeutics Product Portfolio
7.4.2 Pfizer: Financial Overview:
7.5 Roche
7.5.1 Roche: Anti-Inflammatory Therapeutics Product Portfolio
7.5.2 Roche: Financial Overview
7.6 Amgen
7.6.1 Amgen: Anti-Inflammatory Therapeutics Product Portfolio
7.6.2 Amgen: Financial Overview
7.7 Merck
7.7.1 Merck: Anti-Inflammatory Therapeutics Product Portfolio
7.7.2 Merck: Financial Overview
7.8 AbbVie
7.8.1 AbbVie: Anti-Inflammatory Therapeutics Product Portfolio
7.8.2 AbbVie: Financial Overview
7.9 Eli Lilly & Company
7.9.1 Eli Lilly & Company: Anti-Inflammatory Therapeutics Product Portfolio
7.9.2 Eli Lilly & Company: Financial Overview
7.10 AstraZeneca
7.10.1 AstraZeneca: Anti-Inflammatory Therapeutics Product Portfolio
7.10.2 AstraZeneca: Financial Overview
7.11 Other Companies of Interest in the Anti-Inflammatory Therapeutics Market

8. Qualitative Analysis
8.1 SWOT Analysis
8.1.1 Strengths
8.1.1.1 Continuous Innovation and a Strong R&D Pipeline
8.1.1.2 Increasing adoption rate of anti-inflammatory drugs
8.1.2 Weakness
8.1.2.1 Highly Competitive Market
8.1.2.2 Patent Expiries
8.1.3 Opportunities
8.1.3.1 Increasing Prevalence of Diseases
8.1.3.2 Development of Biosimilars for Existing Biologics
8.1.4 Threats
8.1.4.1 Side effects of Anti-Inflammatory Drugs
8.1.4.2 Rising Market for Generics
8.2 Porter Five Forces Analysis
8.2.1 Competitive Rivalry
8.2.2 Bargaining Power of Suppliers
8.2.3 Bargaining Power of Customers
8.2.4 Threat of New Entrants
8.2.5 Threat of New Substitutes

9. Conclusions & Recommendation
9.1 Anti-Inflammatory Therapeutics Market in 2016 and 2017
9.1.1 Anti-Inflammatory Therapeutics Segments Revenue and Market Share in 2016, by Indication
9.1.2 Anti-Inflammatory Therapeutics Segments Revenue and Market Share in 2016, by Drug Class
9.1.3 Leading Anti-Inflammatory Therapeutics Companies
9.1.4 Leading National Markets
9.2 World Anti-Inflammatory Therapeutics Market Forecast 2016-2027
9.3 The Future of Anti-Inflammatory Therapeutics Market

10. Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Visiongain report evaluation form

List of Tables
Table 1.1: Global Anti-Inflammatory Therapeutics Market Forecast by National Market Revenue ($bn), AGR (%) and CAGR (%), 2016-2027
Table 2.1: Feature of Acute and Chronic Inflammation
Table 3.1: Global Anti-Inflammatory Therapeutics, Revenue ($bn), 2016-2027
Table 4.1: Global Anti-Inflammatory Therapeutics Market by Indication: Revenue ($bn), and Market Share (%), 2016-2027
Table 4.2: Global Rheumatoid Arthritis Market by segment: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027
Table 4.3: Global Osteoarthritis Market by segment: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027
Table 4.4: Global Psoriasis Market by segment: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027
Table 4.5: Global Asthma Market by segment: Revenue ($bn), AGR (%), and CAGR (%) 2016-2027
Table 4.6: Global COPD Market by segment: Revenue ($bn), AGR (%), and CAGR (%) 2016-2027
Table 4.7: Global Multiple Sclerosis Market by segment: Revenue ($bn), AGR (%), and CAGR (%) 2016-2027
Table 4.8: Global Ulcerative Colitis Market: Revenue ($bn), AGR (%), and CAGR (%) 2016-2027
Table 4.9: Global Crohn’s Disease Market: Revenue ($bn), AGR (%), and CAGR (%) 2016-2027
Table 4.10: Global Late-stage Pipeline Drugs, 2017
Table 5.1: Global Anti-Inflammatory Therapeutics Market by Drug Class: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027
Table 5.2: Global Corticosteroids Market: Revenue ($bn), AGR (%), CAGR (%), 2016-2027
Table 5.3: Global Anti-Inflammatory Biologics: Revenue ($bn), AGR (%), CAGR (%), 2016-2027
Table 5.4: Global NSAIDs Market: Revenue ($bn), AGR (%), CAGR (%), 2016-2027
Table 5.5: Global Other Anti-Inflammatory Drugs: Revenue ($bn), AGR (%), CAGR (%), 2016-2027
Table 6.1: Global Anti-Inflammatory Therapeutics Market by Region: Revenue ($bn), and Market Share (%), 2016 and 2017
Table 6.2: Global Anti-Inflammatory Therapeutics Market by Region: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027
Table 6.3: US Anti-Inflammatory Therapeutics Market: Revenues ($bn), AGR (%), and CAGR (%), 2016-2027
Table 6.4: EU5 Anti-Inflammatory Therapeutics Market: Revenues ($bn), AGR (%), and CAGR (%), 2016-2027
Table 6.5: UK Anti-Inflammatory Therapeutics Market Forecast: Revenue ($bn), AGR (%), and CAGR (%), 2016-2027
Table 6.6: Germany Anti-Inflammatory Therapeutics Market Forecast: Revenue ($bn), AGR (%), and CAGR (%), 2016-2027
Table 6.7: France Anti-Inflammatory Therapeutics Market Forecast: Revenue ($bn), AGR (%), and CAGR (%), 2016-2027
Table 6.8: Italy Anti-Inflammatory Therapeutics Market Forecast: Revenue ($bn), AGR (%), and CAGR (%), 2016-2027
Table 6.9: Spain Anti-Inflammatory Therapeutics Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027
Table 6.10: Japan Anti-Inflammatory Therapeutics Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027
Table 6.11: Brazil Anti-Inflammatory Therapeutics Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027
Table 6.12: Russian Anti-Inflammatory Therapeutics Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027
Table 6.13: Indian Anti-Inflammatory Therapeutics Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027
Table 6.14 Chinese Anti-Inflammatory Therapeutics Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027
Table 6.15 Rest of the World Anti-Inflammatory Therapeutics Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027
Table 7.1: Johnson & Johnson: Overview, 2017
Table 7.2: Johnson & Johnson: Anti-Inflammatory Therapeutics Product Portfolio
Table 7.3: Johnson & Johnson: Anti-Inflammatory Therapeutics Revenue ($bn), AGR (%) & CAGR (%), 2016-2026
Table 7.4: GlaxoSmithKline: Overview, 2017
Table 7.5: GlaxoSmithKline: Anti-Inflammatory Therapeutics Revenue ($m), AGR (%), CAGR (%), 2016-2027
Table 7.6: Novartis: Overview, 2017
Table 7.7: Novartis: Anti-Inflammatory Therapeutics Revenue ($bn), AGR (%), CAGR (%), 2016-2027
Table 7.8: Pfizer: Overview, 2017
Table 7.9: Pfizer: Anti-Inflammatory Therapeutics Revenue ($bn), AGR (%), CAGR (%), 2016-2027
Table 7.10: Roche: Overview, 2017
Table 7.11: Roche: Anti-Inflammatory Therapeutics Revenue ($m), AGR (%), CAGR (%), 2016-2027
Table 7.12: Amgen: Overview, 2017
Table 7.13: Amgen: Anti-Inflammatory Therapeutics Revenue ($m), AGR (%), CAGR (%), 2016-2027
Table 7.14: Merck: Overview, 2017
Table 7.15: Merck: Anti-Inflammatory Therapeutics Revenue ($m), AGR (%), CAGR (%), 2016-2027
Table 7.16: AbbVie: Overview, 2017
Table 7.17: AbbVie: Anti-Inflammatory Therapeutics Revenue ($m), AGR (%), CAGR (%), 2016-2027
Table 7.18: Eli Lilly & Company: Overview, 2017
Table 7.19: AstraZeneca: Overview, 2017
Table 7.20 Other Companies of Interest in the Anti-Inflammatory Therapeutics Market
Table 8.1: SWOT Analysis of Anti-Inflammatory Therapeutics Market, 2016-2027

List of Figures
Figure 1.1: Projected Prevalence of Arthritis Related Conditions in the US, 2016-2027
Figure 1.2 Global Anti-Inflammatory Therapeutics Market Segmentation, 2017
Figure 3.1: Global Anti-Inflammatory Therapeutics Market, 2016-2027
Figure 3.2: Global Anti-Inflammatory Therapeutics Market by Segment: Drivers and Restraints, 2016-2027
Figure 4.1: Global Anti-Inflammatory Therapeutics Market by Segment: Revenue ($bn), AGR (%), 2017-2027
Figure 4.2: Global Anti-Inflammatory Therapeutics Market by Segment: Market Shares (%), 2016
Figure 4.3: Global Anti-Inflammatory Therapeutics Market by Segment: Market Shares (%), 2021
Figure 4.4: Global Anti-Inflammatory Therapeutics Market by Segment: Market Shares (%), 2021
Figure 4.5: Global Rheumatoid Arthritis Market by Segment: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027
Figure 4.6: Global Osteoarthritis Market by Segment: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027
Figure 4.7: Global Psoriasis Market by Segment: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027
Figure 4.8: Global Asthma Market by segment: Revenue ($bn), AGR (%), and CAGR (%) 2016-2027
Figure 4.9: Global COPD Market by segment: Revenue ($bn), AGR (%), and CAGR (%) 2016-2027
Figure 4.10: Global Multiple Sclerosis Market by segment: Revenue ($bn), AGR (%), and CAGR (%) 2016-2027
Figure 4.11: Global Ulcerative Colitis Market: Revenue ($bn), AGR (%), and CAGR (%) 2016-2027
Figure 4.12: Global Crohn’s Disease Market: Revenue ($bn), AGR (%), and CAGR (%) 2016-2027
Figure 5.1: Global Anti-Inflammatory Therapeutics Market by Drug Class: Revenue ($bn), AGR (%), CAGR (%),2016-2027
Figure 5.2: Global Anti-Inflammatory Therapeutic Market by Drug Class: Market Share (%), 2016
Figure 5.3: Global Anti-Inflammatory Therapeutic Market by Drug Class: Market Share (%), 2021
Figure 5.4: Global Anti-Inflammatory Therapeutic Market by Drug Class: Market Share (%), 2027
Figure 5.5: Global Corticosteroids Market: Revenue ($bn), AGR (%), CAGR (%), 2015-2016
Figure 5.6: Global Anti-Inflammatory Biologics: Revenue ($bn), AGR (%), 2016-2027
Figure 5.7: Global NSAIDs Market Revenue ($bn), AGR (%), CAGR (%), 2016-2027
Figure 5.8: Global Other Anti-Inflammatory Drugs Market: Revenue ($bn), AGR (%), CAGR (%), 2016-2027
Figure 6.1: Global Anti-Inflammatory Therapeutics Market by Region: Revenue ($bn), and Market Share (%), 2016
Figure 6.2: Global Anti-Inflammatory Therapeutics Market by Region: Revenue ($bn), and Market Share (%), 2017
Figure 6.3: Global Anti-Inflammatory Therapeutics Market by Region: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027
Figure 6.4: Global Anti-Inflammatory Therapeutics by Region: Market Shares (%), 2016
Figure 6.5: Global Anti-Inflammatory Therapeutics Market by Region: Market Shares (%), 2021
Figure 6.6: Global Anti-Inflammatory Therapeutics Market by Region: Market Shares (%), 2027
Figure 6.7: US Anti-Inflammatory Therapeutics Market: Revenues ($bn), AGR (%), and CAGR (%), 2016-2027
Figure 6.8: EU5 Anti-Inflammatory Therapeutics Market: Revenues ($bn), AGR (%), and CAGR (%), 2016-2027
Figure 6.9: EU5 Anti-Inflammatory Therapeutics Market: Market Shares (%) by National Market, 2016
Figure 6.10: EU5 Anti-Inflammatory Therapeutics Market: Market Shares (%) by National Market, 2021
Figure 6.11: EU5 Anti-Inflammatory Therapeutics Market: Market Shares (%) by National Market, 2027
Figure 6.12: UK Anti-Inflammatory Therapeutics Market Forecast: Revenue ($bn), AGR (%), and CAGR (%), 2016-2027
Figure 6.13: Germany Anti-Inflammatory Therapeutics Market Forecast: Revenue ($bn), AGR (%), and CAGR (%), 2016-2027
Figure 6.14: France Anti-Inflammatory Therapeutics Market Forecast: Revenue ($bn), AGR (%), and CAGR (%), 2016-2027
Figure 6.15: Italy Anti-Inflammatory Therapeutics Market Forecast: Revenue ($bn), AGR (%), and CAGR (%), 2016-2027
Figure 6.16: Spain Anti-Inflammatory Therapeutics Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027
Figure 6.17: Japan Anti-Inflammatory Therapeutics Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027
Figure 6.18: Brazil Anti-Inflammatory Therapeutics Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027
Figure 6.19: Russian Anti-Inflammatory Therapeutics Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027
Figure 6.20: Indian Anti-Inflammatory Therapeutics Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027
Figure 6.21: Chinese Anti-Inflammatory Therapeutics Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027
Figure 6.22: Rest of the World Anti-Inflammatory Therapeutics Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027
Figure 7.1: Johnson & Johnson: Anti-Inflammatory Therapeutics Revenue ($bn), AGR (%), CAGR (%), 2016-2027
Figure 7.2: GlaxoSmithKline: Anti-Inflammatory Therapeutics Revenue ($m), AGR (%), CAGR (%), 2016-2027
Figure 7.3: Novartis: Anti-Inflammatory Therapeutics Revenue ($bn), AGR (%), CAGR (%), 2016-2027
Figure 7.4: Pfizer: Anti-Inflammatory Therapeutics Revenue ($bn), AGR (%), CAGR (%), 2016-2027
Figure 7.5: Roche: Anti-Inflammatory Therapeutics Revenue ($bn), AGR (%), CAGR (%), 2016-2027
Figure 7.6: Amgen: Anti-Inflammatory Therapeutics Revenue ($bn), AGR (%), CAGR (%), 2016-2027
Figure 7.7: Merck: Anti-Inflammatory Therapeutics Revenue ($bn), AGR (%), CAGR (%), 2016-2027
Figure 7.8: AbbVie: Anti-Inflammatory Therapeutics Revenue ($bn), AGR (%), CAGR (%), 2016-2027

【レポートのキーワード】

消炎剤、消炎治療

★調査レポート[消炎剤の世界市場予測] (コード:VGAIN7081170)販売に関する免責事項を必ずご確認ください。
★調査レポート[消炎剤の世界市場予測]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆